(Reuters) - Diagnostic services provider LabCorp said on Thursday it would make its COVID-19 tests available at workplaces, as employers across the United States look to bring people back to work ...

(Reuters) - LabCorp said on Thursday it has launched a new test that could assess the capacity of antibodies in patient plasma to inhibit the novel coronavirus. Information from the test about the ...

The US Food and Drug Administration (FDA) on Tuesday granted an emergency use authorization (EUA) to LabCorp allowing it to test self-collected nasal swab samples from patients for coronavirus disease ...

BURLINGTON, N.C. (WJZY) — North Carolina-based LabCorp announced Tuesday that it has received an Emergency Use Authorization from the U.S. Food and Drug Administration for at-home COVID-19 test kits.

UNITED STATES - The Food and Drug Administration authorized the first diagnostic test with a home collection option for COVID-19 on Tuesday, according to a news release from the agency. The LabCorp ...

Select independently determines what we cover and recommend. When you buy through our links, we may earn a commission. Learn more. At-home Covid tests can diagnose infection and are in stock now ...

Home self-test kits to detect COVID-19 offer convenience and fast results. Several players in the market promote their own versions. For example, with a prescription and $25, BinaxNOW provides their ...

Labcorp CEO Adam Schechter on Tuesday urged Americans to be vaccinated against Covid-19 and told CNBC that recipients are not being advised to be tested for Covid antibodies afterward. "At the moment, ...

Our editors independently selected these items because we think you will enjoy them and might like them at these prices. If you purchase something through our links, we may earn a commission. Pricing ...

LabCorp posted first-quarter results that were generally consistent with our expectations, and we’re holding steady in our fair value estimate, as nothing in the quarter prompted us to materially ...

LabCorp posted full-year results that ran ahead of our expectations on the top and bottom lines for 2021. However, that outperformance was offset after adjusting our 2022 projections downward as ...